학술논문
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
Document Type
Article
Author
Gianni, Luca; Dafni, Urania; Gelber, Richard D; Azambuja, Evandro; Muehlbauer, Susanne; Goldhirsch, Aron; Untch, Michael; Smith, Ian; Baselga, José; Jackisch, Christian; Cameron, David; Mano, Max; Pedrini, José Luiz; Veronesi, Andrea; Mendiola, Cesar; Pluzanska, Anna; Semiglazov, Vladimir; Vrdoljak, Eduard; Eckart, Michael J; Shen, Zhenzhou; Skiadopoulos, George; Procter, Marion; Pritchard, Kathleen I; Piccart-Gebhart, Martine J; Bell, Richard
Source
In Lancet Oncology 2011 12(3):236-244
Subject
Language
ISSN
1470-2045